Home 2023
Archives
The next frontier in anti-cancer drugs
Dr Anthony J. Berdis, Case Comprehensive Cancer Center discusses the future of cancer treatments and anti-cancer drugs.
Recent advancements in artificial blood technology
Professor Allan Doctor from the University of Maryland School of Medicine shares promising developments regarding the creation of safe and effective artificial blood products.
Potential implications of cosmetic BoNT-A use on future treatment options for neuromuscular disorders and...
Given the rise in cosmetic procedures involving BoNT-A, cosmetic physician Dr Mary Dingley discusses the therapeutic implications of antibody-induced resistance on future treatment of various conditions, including post-stroke spacticity and pain disorders.
Developing novel treatments for childhood solid cancers
With a particular focus on glioma, Dr Peter J Houghton from Greehey Children’s Cancer Research Institute outlines the barriers that have hindered the development of effective therapies for childhood solid cancers.
Leveraging psychedelic therapies for binge eating disorder
Here Tryp Therapeutics examine the viability of using psychedelic therapies for Binge Eating Disorder and the potential results that using psychedelic-assisted psychotherapy could have on different eating disorders.
E-Learning platform for dementia caregivers
Jockey Club Centre for Positive Ageing is developing a multimedia e-learning platform for dementia caregivers; here, they share the vast benefits.
Classification of rare diseases: The case of the ultra-and hyper-rare
Dr C. I. Edvard Smith, Dr Daniel W. Hagey and Dr Rula Zain, from the Karolinska Institutet in Sweden, note that there is an almost infinite number of unique diseases, contributing to the challenges with the classification of rare diseases.
Drug repositioning without the gene expression of disease cells treated with drugs
Y-h. Taguchi, Professor at the Department of Physics, Chuo University in Japan, provides comments on drug repositioning without the gene expression of disease cells treated with various drugs.
LIFU for major depressive disorder – Targeting the neural networks of depression
Tiago Costa, Assistant Professor at the Department of Microelectronics, Delft University of Technology, discusses opportunities surrounding low-intensity focused ultrasound in the treatment of major depressive disorder in a minimally invasive manner.
Investigating OTC drugs: Are over-the-counter drugs an under-appreciated toxic danger?
Contrary to popular belief, OTC drugs are not harmless. Understanding the effects and dangers of OCT abuse and misuse is key to public safety, here UC Davis provides everything you need to know.
The history of psychedelics and why psychedelic stories matter
Erika Dyck delves into the history of psychedelics, exploring how these substances have piqued the interest and influenced the attitudes of individuals across academia, culture, and medicine.
Photodynamic Therapy: Killing cancer gently with visible light
Photodynamic therapy, using visible light with lower energy, causes fewer side effects when treating cancer, find Drs. Mary Potasek, Evgueni Parilov, and Karl Beeson, Co-founders of Simphotek, Inc.
Understanding thermolabile protecting groups for nucleic acid-based drugs
Serge L. Beaucage investigates thermolabile protecting groups for the amine functions of purine and pyrimidine deoxyribonucleosides for the development and implementation of synthetic DNA sequences as nucleic acid-based drugs.
Applying data science advances in disease surveillance and control
Dr. David S. Ebert from the University of Oklahoma’s Data Institute for Societal Challenges and Dr. Aaron Wendelboe from the University of Oklahoma Health Sciences Center outline how a cohesive, multidisciplinary, and multi-tiered approach can support a more predictive model in disease surveillance and control.
The emergence of precision medicine for oncology
Dr Priya Hays, PhD, considers how the rapid development of precision medicine for oncology has impacted diagnosis, treatment, and clinical outcomes in cancer care.
IC2PERMED: Fostering collaboration between Europe and China to enhance personalised medicine
Tailoring care to meet patients’ needs can dramatically improve clinical outcomes; we hear how the IC2PerMed project is bolstering efforts in personalised medicine.
Recording and decoding neural signals from the vagus nerve
Dominique M Durand, distinguished Professor of Biomedical Engineering, Case Western Reserve University, Cleveland Ohio, USA, discusses the study of neural signals from the vagus nerve.
New care models for older adults seeking emergency care
Professors Katie Robinson and Rose Galvin from the Ageing Research Centre at the University of Limerick describe research on new models of care for older adults seeking emergency care.
Ovarian cancer research: Examining ovarian function and dysfunction
JoAnne S Richards, PhD, Professor at Baylor College of Medicine, explores ovarian cancer research with a focus on ovarian function and dysfunction.
Injury prevention research to reduce youth-sport related injuries
Dr Carolyn Emery highlights injury prevention research in informing best practices and policies to reduce the burden of sport-related injuries and concussions in youth sports.